Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

被引：0
|
作者：
Dongwoo Kang
Elizabeth Ludwig
David Jaworowicz
Hannah Huang
Jill Fiedler-Kelly
Jorge Cortes
Siddhartha Ganguly
Samer Khaled
Alwin Krämer
Mark Levis
Giovanni Martinelli
Alexander Perl
Nigel Russell
Malaz Abutarif
Youngsook Choi
Ophelia Yin
机构：
[1] Daiichi Sankyo,Clinical Cooperation Unit Molecular Hematology/Oncology, Department of Internal Medicine V
[2] Inc,Division of Hematology and Oncology, Abramson Cancer Center
[3] Cognigen Corporation,Centre for Clinical Haematology
[4] a Simulations Plus Company,undefined
[5] Georgia Cancer Center at Augusta University,undefined
[6] University of Kansas Cancer Center,undefined
[7] City of Hope,undefined
[8] University of Heidelberg,undefined
[9] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University,undefined
[10] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,undefined
[11] University of Pennsylvania,undefined
[12] Nottingham University Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
Concentration–QTc analysis; Quizartinib; AC886; Relapsed/refractory; Acute myeloid leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：513 / 523
页数：10
相关论文
共 50 条
  • [21] Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoecker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    BLOOD, 2014, 124 (21)
  • [22] Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
    Lindblad, Katherine E.
    Thompson, Julie
    Gui, Gege
    Valdez, Janet
    Worthy, Tatyana
    Tekleab, Hanna
    Hughes, Tom
    Goswami, Meghali
    Oetjen, Karolyn
    Kim, Dong-Yun
    Dillon, Laura
    DeStefano, Christin
    Lai, Catherine E.
    Hourigan, Christopher S.
    BLOOD, 2018, 132
  • [23] Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia
    DiNardo, Courtney D.
    Cortes, Jorge E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 265 - 272
  • [24] Progress in the problem of relapsed or refractory acute myeloid leukemia
    Mims, Alice S.
    Blum, William
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (02) : 88 - 95
  • [25] Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
    Goswami, Meghali
    Gui, Gege
    Dillon, Laura W.
    Lindblad, Katherine E.
    Thompson, Julie
    Valdez, Janet
    Kim, Dong-Yun
    Ghannam, Jack Y.
    Oetjen, Karolyn A.
    Destefano, Christin B.
    Smith, Dana M.
    Tekleab, Hanna
    Li, Yeusheng
    Dagur, Pradeep
    Hughes, Thomas
    Marte, Jennifer L.
    del Rivero, Jaydira
    Klubo-Gwiezdzinksa, Joanna
    Gulley, James L.
    Calvo, Katherine R.
    Lai, Catherine
    Hourigan, Christopher S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [26] Relapsed/refractory acute myeloid leukemia: any progress?
    Schlenk, Richard F.
    Mueller-Tidow, Carsten
    Benner, Axel
    Kieser, Meinhard
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (06) : 467 - 473
  • [27] Novel strategies for relapsed and refractory acute myeloid leukemia
    Mato, Anthony R.
    Morgans, Alicia
    Luger, Selina M.
    CURRENT OPINION IN HEMATOLOGY, 2008, 15 (02) : 108 - 114
  • [28] Salvage therapy for relapsed or refractory acute myeloid leukemia
    Mangan, James K.
    Luger, Selina M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (02) : 73 - 82
  • [29] Quizartinib in FLT3-ITD-Mutated Relapsed/Refractory Acute Myeloid Leukemia: QuANTUM-R Trial Results
    Cortes, Jorge E.
    Khaled, Samer
    Martinelli, Giovanni
    Perl, Alexander E.
    Ganguly, Siddhartha
    Russell, Nigel H.
    Kramer, Alwin
    Dombret, Herve
    Hogge, Donna
    Jonas, Brian A.
    Leung, Anskar Yh
    Mehta, Priyanka
    Montesinos, Pau
    Radsak, Markus P.
    Sica, Simona
    Arunachalam, Meena
    Holmes, Melissa
    Namuyinga, Ruth
    Zhang, Yufen
    Levis, Mark J.
    ANNALS OF ONCOLOGY, 2019, 30 : 81 - 81
  • [30] Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
    Piccaluga, PP
    Martinelli, G
    Rondoni, M
    Malagola, M
    Gaitani, S
    Isidori, A
    Bonini, A
    Gugliotta, L
    Luppi, M
    Morselli, M
    Sparaventi, G
    Visani, G
    Baccarani, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1791 - 1795
12345